In this inaugural CLL Global Research Foundation Virtual Town Hall, the expert panel included CLL Global founder, Dr. Michael Keating, CLL Global president, Dr. Bill Wierda, and CLL Global grant recipient, Dr. Phillip Thompson.
Dr. Michael Keating, Founder, CLL Global Research Foundation
Dr. William Wierda, President & CEO, CLL Global Research Foundation
Dr. Phillip Thompson, CLL Global Research Foundation Grant Recipient
Jeff Folloder, Moderator and CLL patient advocate
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
